Woodworth T G, Abuelo J G, Austin H A, Esparza A
Medicine (Baltimore). 1987 May;66(3):181-91. doi: 10.1097/00005792-198705000-00002.
We have analyzed an unusual group of 19 patients (15 previously reported) with Wegener's granulomatosis, who presented with severe glomerulonephritis and developed diagnostic respiratory lesions only after 4 to 78 months. Necrotizing glomerulonephritis, often with crescents, and rarely with vasculitis, was the predominant renal lesion. Wegener's granulomatosis was unsuspected initially, since systemic manifestations, such as fever, arthralgias, malaise, and even pulmonary hemorrhage, were nonspecific or transient, and because renal biopsy findings resembled those seen in microscopic polyarteritis or idiopathic crescentic nephritis. Despite therapy, usually with corticosteroids, only 4 patients maintained adequate renal function. Most patients were receiving chronic dialysis when respiratory involvement developed. Cavitary nodular pulmonary infiltrates were seen in 12 of the 17 patients with lung involvement, and otorhinological disease occurred in 10 patients. Arthralgias, fever, and cough, with or without hemoptysis, were common. Wegener's granulomatosis was diagnosed by lung biopsy in 15 cases and by nasal biopsy in 4. Specific treatment was required for the respiratory disease and was delayed in many patients, because of lack of awareness that Wegener's granulomatosis may present with primary glomerulonephritis and become active during chronic renal failure or dialysis. Nevertheless, all but 1 patient eventually responded to treatment, although 3 additional patients died of late complications.
我们分析了一组特殊的19例韦格纳肉芽肿病患者(此前报告过15例),这些患者表现为严重肾小球肾炎,在4至78个月后才出现诊断性呼吸道病变。坏死性肾小球肾炎,常伴有新月体形成,很少伴有血管炎,是主要的肾脏病变。最初未怀疑韦格纳肉芽肿病,因为发热、关节痛、不适甚至肺出血等全身表现是非特异性的或短暂的,而且肾活检结果类似于显微镜下多动脉炎或特发性新月体性肾炎所见。尽管通常使用皮质类固醇进行治疗,但只有4例患者维持了足够的肾功能。大多数患者在出现呼吸道受累时正在接受慢性透析。17例肺部受累患者中有12例出现空洞性结节性肺浸润,10例患者出现耳鼻喉疾病。关节痛、发热和咳嗽,伴或不伴咯血,很常见。15例通过肺活检诊断为韦格纳肉芽肿病,4例通过鼻活检诊断。呼吸道疾病需要特异性治疗,许多患者的治疗被延迟,因为没有意识到韦格纳肉芽肿病可能以原发性肾小球肾炎为表现,并在慢性肾衰竭或透析期间变得活跃。然而,除1例患者外,所有患者最终对治疗有反应,尽管另有3例患者死于晚期并发症。